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Abstract 
We established SGC-7901 nude mice xenograft tumor model, depicted the growth curve of the tumor, calculated the 
tumor inhibition rate after the treatment with total flavonoids from Chrysanthemum and observed the pathological 
changes in tumor by light microscopy. The results showed that total flavonoids from Chrysanthemum can inhibit the 
growth of SGC-7901 cells in nude mice xenograft tumor, the weight inhibition rates of xenograft tumor treated with 
100 mg•kg-1, 200 mg•kg-1 and 500 mg•kg-1 Chrysanthemum flavonoids were  30.4%, 36.7% and 59.4%, with a 
concentration-dependent. With pathological observations, Chrysanthemum flavonoids can induce SGC-7901 cells 
necrosis and apoptosis. Therefore, total flavonoids from Chrysanthemum can inhibit growth and proliferation of 
SGC-7901 cells, and induce apoptosis in vivo. 
 
© 2011 Published by Elsevier Ltd. Selection and/or peer-review under responsibility of Society for 
Resources, Environment and Engineering 
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1. Introduction 
Chrysanthemum, slightly sweet, slightly cold, is one of famous traditional Chinese medicine-Zhejiang 
Bawei, which eight kinds of Chinese herbal medicines produced in Zhejiang Province, Eastern China [1-
11]. Chrysanthemum has effects of nourishing the liver to improve visual acuity, clearing heat, removing 
toxicity, anti-inflammatory and so on, is a common medicine in traditional Chinese medicine prescription 
[6-9]. According to domestic and foreign reports and our preliminary experiment, the main chemical 
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compositionin for anti-tumor in Chrysanthemum are flavonoids, parthenolide, hydroxy triterpenes, 
selenium, chlorogenic acid, etc [10-15]. We have extracted total flavonoids from Chrysanthemum 
cooperation with Zhejiang Conba Pharmaceutical Co., LTD. which in Hangzhou, the capital of Zhejiang 
Province. In order to further explore its anti-tumor activity, determine the activity of total flavonoids from 
Chrysanthemum on confronting human gastric cancer SGC-7901 cells. 
2. Materials and Methods 
2.1. Drugs and reagents 
Total flavonoids from Chrysanthemum were provided from Zhejiang Conba Pharmaceutical Co., LTD. 
The fluorouracil were purchased from Hisun, China, the newborn calf serum were purchased from 
Evergreen Bio-Engi-Materi of China, PRM I 1640 medium were purchased from Gibco of USA, and the 
sodium carboxymethyl cellulose (CMC-Na) were purchased from Amresco of USA. 
2.2. Cells and cell cultures 
Human gastric cancer SGC-7901 cells line were provided from Zhejiang Cancer Research Institute of 
China, with 10% fetal calf serum (FCS) in RPM I 1640 medium 1 times for cell culture passage for 2 to 3 
days, took logarithmic phase cells used in the experiment. 
2.3. Experimental animals 
50 mice which were mutant SPF level Bal b/c-nu male, 6 to 7 w, weighing 18-23 g, purchased from 
the Experimental Animal Center, Hangzhou Normal University, freely given sterile water and feed, fed in 
one hundred sterile room. The food, water, litter, cages were sterilized before use by high-pressure steam. 
The care and handling of the animals was in accordance with the Chinese Association for Laboratory 
Animal Sciences. 
2.4. Animal model and drug treatment 
Digested logarithmic phase human gastric cancer SGC-7901 cells with trypsin, prepared cell 
suspension (1×107/L) and inoculated into nude mice subcutaneous on back for 0.2 ml each. Until the 
tumor volume reached 300 mm3 or more, according to the balance principles of the tumor volume and 
mice weight, mice were randomly divided into five groups. The control group: 0.7% CMC-Na, 10 mg•kg-
1, the fluorouracil group: fluorouracil 25 mg•kg-1, the Chrysanthemum flavonoids low dose group: 
flavonoids 100 mg•kg-1, the Chrysanthemum flavonoids medium dose group: flavonoids 200 mg•kg-1, the 
Chrysanthemum flavonoids high dose group: flavonoids 500 mg•kg-1. The above groups were used daily 
intraperitoneal injection, a total of 10 times, and detected indicators in 48 h after the last administration. 
2.5. Tumor growth curve mapping 
The living conditions of nude mice were observed daily, and measured the maximum tumor diameter 
(L) and shortest diameter (W) by a vernier caliper during the administration every 2 days. The tumor 
volume (V) was calculated according to general formula 
L × W2 × 0.52 = V. 
The tumor growth curve was drawn according to the tumor mean volumes. 
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2.6. The rate of tumor weight inhibition 
Mice were killed by cervical dislocation on 48 h after the last administration. Then removal of tumor, 
weighted tumor with dish-type electronic analytical balance, calculated tumor weight inhibition rate (R) 
according to the mean tumor weight of experimental group (WE) and the mean tumor weight in control 
group (WC) 
(1 - WE / WC) × 100% = R. 
2.7. Pathological observation 
Tumor tissue removed place into 10% formalin PBS solution for fix, conventional dehydration, 
transparent tissue with xylene, embed in paraffin. The thickness of tissue section was 4 μm, dewaxed by 
xylene for 5 min and 10min, ethanol (100%) for 5 min and 5 min, ethanol (95%) for 3 min, distilled water 
for 2 min, hematoxylin staining for 5 min, hydrochloric acid (1%) for 5-10 sec, distilled water for 2 min 
10 min, eosin (0.5%) for 0.5-1 min, ethanol (95%) for 5 min and 5 min, ethanol (100%) for 5min and 2 
min, xylene for 3 min and 5 min, then enveloped by neutral gum. 
2.8. Statistical analysis 
Using SPSS 13.0 statistical software analysis, data are expressed as Mean ± SD. All experiments were 
repeated three times with giving similar results. We used a Student’s t-test or ANOVA for statistical 
comparisons of means. 
3. Results 
3.1. The growth curve of xenografts tumor 
Tumor volumes of between the groups were significant differences (P<0.01, P<0.05), these were dose-
dependent and time-dependent for inhibition of xenograft tumor growth of total flavonoids from 
Chrysanthemum in human gastric cancer SGC-7901 nude mice, as shown in Fig. 1.  
Fig.1. The growth curve of xenografts tumor in each group (mean ± SD) 
*P<0.05, **P<0.01 vs control group (CMC-Na); CF: Chrysanthemum flavonoids 
         
* 
** 
 
** 
** 
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3.2. The weight of nude mice with xenografts tumor 
During the administration, in nude mice SGC-7901 xenograft tumor model, the body weight of nude 
mice of fluorouracil group loss 37.47% (P<0.01), and appear gradually several symptoms, such as lack of 
appetite, decreasing activity, body bruising and so on. The mice of the control group and Chrysanthemum 
flavonoids groups have no difference in body weight change, stable living conditions. The results 
suggested the total flavonoids from Chrysanthemum have not toxicity on nude mice. The results could be 
seen at Tab. 1.  
3.3. The weight and inhibition rate of xenografts tumor 
The tumor weight of treatment groups was significantly lower than the control group (P<0.05), the 
average inhibition rates were 66.4%, 30.4%, 36.7% and 59.4% in fluorouracil group and Chrysanthemum 
flavonoids groups (100 mg•kg-1, 200 mg•kg-1, and 500 mg•kg-1), as shown in Tab.1 
Table 1. The effect of different dose on the xenografts tumor weight (mean ± SD, n=10) 
Groups Dose (mg•kg-1) 
Body weight (g) 
Tumor weight (mg) Inhibitory rate (%) 
Before After 
CMC-Na 10 22.25 ± 2.10 22.58 ± 2.42 2876 ±  627 - 
Fluorouracil 25 21.86 ± 2.21 13.67 ± 1.24** 968 ± 204** 66.4 
CF 100 22.55 ± 2.15 22.69 ± 3.06 2003 ± 285* 30.4 
CF ¹ 200 22.34 ± 2.02 21.37 ± 1.86 1820 ± 324** 36.7 
CF 500 21.96 ± 2.36 22.52 ± 2.08 1168 ± 319** 59.4 
*P<0.05, **P<0.01 vs control group (CMC-Na); CF: Chrysanthemum flavonoids 
3.4. The pathological morphology of xenografts tumor 
Histopathology examination, the cancer cell nuclear of each group was large, stained dark, which were 
round, oval and irregular shape, some nucleoli were visible, and cytoplasmic slightly-transparent, there 
were more eosinophilic granules. Tumor cells were arranged in cords, and even solid-like structure group, 
showing obvious pathological mitosis in the control group. Tubular structure of tumor cells can be seen 
clearly, and shows large areas of necrosis in Chrysanthemum flavonoids high-dose group. HE staining is 
shown as Fig. 2. 
   
Fig. 2.  Left: control group; Right: Chrysanthemum flavonoids high doses group 
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4. Discussion 
Gastric cancer is one of the most common gastrointestinal malignancies, its incidence and mortality 
rates remain higher [16]. Looking for a high efficient and low toxicity plant extracts to treat gastric cancer 
medicine, has become a research hotspot. It has been confirmed that variety of plant extracts, such as 
diallyl disulfide (DADS) and matrine, which have an effect on human gastric cancer [12-15]. In this study, 
we attempts to develop new drugs for the treatment of gastric cancer clinical study to provide 
experimental basis through evaluating the inhibiting effect of chrysanthemum flavonoids on human 
gastric cancer SGC-7901 cells. 
Chrysanthemum (Flos Chrysanthemi) is the Asteraceae Chrysanthemum plant, semi-woody perennial 
herb. As a medicinal plant, it first appeared in “Shennong Ben Cao Jing” in the Eastern Han Dynasty of 
China [17]. According to “Chinese Pharmacopoeia (2010 edition)” recorded, the main medicinal 
Chrysanthemum are four varieties, that is Chuju, Haoju, Gongju and Hangju. The main chemical 
compositionin for anti-tumor in Chrysanthemum are flavonoids, parthenolide, hydroxy triterpenes, 
selenium, chlorogenic acid, etc [16-22]. Representative of the flavonoid compounds including: casticin, 
luteolin, Ai Hong Su, homoorientin and other elements [21]. Recent research has found that casticin could 
inhibit growing of KB cells of human oral squamous cell carcinoma, PC-12 cells of human lung cancer 
and HCT116 cells of human colon cancer [20-23]. In addition, Chrysanthemum flooding fluid has a 
significant scavenging on superoxide anion which is produced by light riboflavin, the ability of 
scavenging oxygen free radicals and the content of polyphenols and flavonoids are positive correlation.  
To confirm the Chrysanthemum flavonoids have a direct inhibitory effect for human gastric cancer 
SGC-7901 cells, this study established SGC-7901 xenograft tumor model in nude mice to observe the 
Chrysanthemum flavonoids on inhibition of tumor growth in nude mice. The results showed that, low, 
medium and high doses of Chrysanthemum flavonoids can effectively inhibit tumor growth in nude mice 
compared with the control group, and inhibition of high-dose group was significantly greater than the low 
dose group (P<0.05). It shows that Chrysanthemum flavonoids can inhibit growth and proliferation of 
human gastric cancer cells. 
Apoptosis is an important factor in the process of tumor development, and apoptosis is significantly 
reduced in malignant tumor [19-23]. Once inducing tumor cell apoptosis tumor development inhibited. In 
this study, light microscopy showed that tumor necrosis in Chrysanthemum flavonoids high doses group 
is much more than control group. 
In summary, Chrysanthemum flavonoids can inhibit the proliferation of SGC-7901 cells, and in the 
experimental dose, its toxicity is not obvious, it is a great potential of human gastric cancer candidate 
drug, but it will need further study for specific anti-tumor effect mechanism in vivo, pharmacokinetics.  
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